Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-27FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd.)
The FDA approved Advagen Pharma Ltd.'s supplemental application for dorzolamide hydrochloride, authorizing a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial evaluating the efficacy and safety of OPC-1085EL ophthalmic solution in glaucoma or ocular hypertension has completed and resu…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 study evaluating the efficacy and safety of OPC-1085EL ophthalmic solution in glaucoma or ocular hypertension completed with results…
-
FDA approval · 2015-11-10FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brinzolamide submitted by Sandoz Inc under NDA 020816, reflecting an approved modification t…
-
FDA approval · 2015-11-10FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 clinical trial assessing the safety and efficacy of a triple combination therapy in patients with primary open-angle glaucoma or ocu…
-
FDA approval · 2015-11-05FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)
The FDA approved a supplemental application to market IOPIDINE 1% (apraclonidine hydrochloride ophthalmic solution) under Harrow Eye, LLC. T…
-
FDA approval · 2015-11-05FDA Approved: SIMBRINZA — Supplemental Application (Alcon Laboratories, Inc.)
FDA approved a supplemental application for SIMBRINZA (brinzolamide/brimonidine tartrate) submitted by Alcon Laboratories, Inc.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study [Phase 4]
A Phase 4, European multicenter, investigator-led trial comparing preservative-free bimatoprost and latanoprost on intraocular pressure and …
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: A Study of Bimatoprost 0.01% in the Clinical Setting
The document reports the completion of a clinical trial evaluating bimatoprost 0.01% for primary open-angle glaucoma and ocular hypertension…
-
FDA label_change · 2015-10-20FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)
FDA granted a supplemental approval for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb, updating the product labeling per the supplemental…
-
FDA approval · 2015-10-15FDA Approved: COMBIGAN — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for COMBIGAN (brimonidine tartrate, timolol maleate) submitted by Allergan, Inc., updating the produ…
-
CLINICAL_TRIALS research · 2015-10-14Clinical Trial Update: Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow
This entry provides a clinical trial update on how marijuana use may affect optic nerve measurements and blood flow in the eye, with intraoc…
-
FDA approval · 2015-10-08FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb Incorporated.
-
FDA label_change · 2015-10-06FDA Approved: TIMOLOL MALEATE — Supplemental Application (Pacific Pharma, Inc.)
FDA approved a supplemental application for timolol maleate from Pacific Pharma, Inc. to update the drug’s labeling.
-
FDA approval · 2015-10-06FDA Approved: TIMOLOL MALEATE — Supplemental Application (Pacific Pharma, Inc.)
The FDA approved a supplemental application for Timolol Maleate from Pacific Pharma, Inc., under an approved supplemental submission.
-
CLINICAL_TRIALS trial_result · 2015-09-21Clinical Trial Update: A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
Allergan-sponsored clinical trial of Simbrinza for open-angle glaucoma or ocular hypertension has completed. The provided snippet does not i…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of LX7101 in subjects with primary open-angle glaucoma or ocula…
-
FDA approval · 2015-09-04FDA Approved: TAFLUPROST OPHTHALMIC — Supplemental Application (Prasco Laboratories)
FDA notes a supplemental application for Tafluprost Ophthalmic (TAFLUPROST) submitted by Prasco Laboratories. The document indicates the sta…
-
FDA label_change · 2015-08-14FDA Approved: TIMOPTIC IN OCUDOSE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC IN OCUDOSE (timolol maleate) from Bausch & Lomb Incorporated.
-
FDA approval · 2015-07-31FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)
FDA approved a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) submitted by Thea Pharma Inc. The product…
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension [Phase 4]
A Phase 4 trial comparing AZARGA to COSOPT in open-angle glaucoma or ocular hypertension has completed, providing comparative efficacy data.
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea
This completed Korean clinical trial evaluated the safety and efficacy of Ganfort (bimatoprost/timolol) ophthalmic solution. It enrolled pat…
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma [Phase 4]
Phase 4 clinical trial assessing intraocular pressure reduction with Travoprost ophthalmic solution in normal tension glaucoma. Results have…
-
FDA approval · 2015-07-20FDA Approved: BIMATOPROST — Original Application (Apotex Corp.)
FDA approved the original application for bimatoprost from Apotex Corp, granting approval for a generic ophthalmic solution. Bimatoprost is …